Zoetis Inc. (ZTS) Profit Margin
Zoetis Inc. (ZTS) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | 16.80% |
| 2017-12-31 | 16.28% |
| 2018-12-31 | 24.52% |
| 2019-12-31 | 23.96% |
| 2020-12-31 | 24.54% |
| 2021-12-31 | 26.20% |
| 2022-12-31 | 26.16% |
| 2023-12-31 | 27.43% |
| 2024-12-31 | 26.86% |
| 2025-12-31 | 28.23% |
How ZTS compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| LLY | Eli Lilly and Company | 31.67% |
| REGN | Regeneron Pharmaceuticals Inc. | 31.41% |
| GILD | Gilead Sciences Inc. | 28.90% |
| JNJ | Johnson & Johnson | 28.46% |
| INCY | Incyte Corporation | 25.03% |
These are five companies in the same sector as ZTS with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Zoetis Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("ZTS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ZTS | $74.80 | -0.05% | 1.83M |
| 3 | ||||
| 4 | ||||
| 5 |